2-(2-pyridyl)-1(3)H-imidazo[4,5-c]pyridine | 14060-62-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并吡啶类
• 英文名称: 2-(2-pyridyl)-1(3)H-imidazo[4,5-c]pyridine
• 英文别名: 3H-Imidazo[4,5-c]pyridine, 2-(2-pyridinyl)-；2-pyridin-2-yl-3H-imidazo[4,5-c]pyridine
• CAS: 14060-62-9
• 化学式: C₁₁H₈N₄
• 分子量: 196.211
• InChiKey: RCQLXXHLXWNHOU-UHFFFAOYSA-N

物化性质

• 熔点：
  232 °C(Solv: ethanol (64-17-5))
• 沸点：
  465.4±43.0 °C(Predicted)
• 密度：
  1.336±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  54.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(2-pyridyl)-1(3)H-imidazo[4,5-c]pyridine 、 对溴溴苄 在 sodium hydroxide 作用下， 以 DMF (N,N-dimethyl-formamide) 、 水 为溶剂， 反应 24.25h， 以43%的产率得到5-[(4-bromophenyl)methyl]-2-(2-pyridinyl)-5H-imidazo[4,5-c]pyridine
  参考文献：
  名称：

  [EN] VIRAL INHIBITORS
  [FR] INHIBITEURS VIRAUX

  摘要：

  公开号：

  WO2004005286A3
• 作为产物：
  描述：

  4-乙氧基-3-硝基吡啶 在 盐酸 、 五羰基铁 、 sulfur 作用下， 以 乙醚 、 乙醇 、 水 为溶剂， 反应 4.25h， 生成 2-(2-pyridyl)-1(3)H-imidazo[4,5-c]pyridine
  参考文献：
  名称：

  2-杂芳基取代的咪唑并[4,5-b]-吡啶和咪唑并[4,5-c]吡啶的合成及PMR光谱

  摘要：

  DOI：

  10.1007/bf00472751

文献信息

• Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators
  申请人：Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

  公开号：EP2818472A1

  公开（公告）日：2014-12-31

  The present invention relates to imidazo[5,4-c]pyridine or pyrrolo[3,2-c]pyridine compounds and stereoisomeric forms, solvates, hydrates and/or pharmaceutically acceptable salts of these compounds, as well as pharmaceutical compositions containing at least one of these pyridine-based bicyclic compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said pyridine-based bicyclic compounds are assumed to be modulators of the GRK5 protein, thereby regulating the expression and/or release of insulin and are useful for the treatment or prophylaxis of a metabolic disease and in particular for the treatment and prophylaxis of diabetes, obesity and impaired adipogenesis.

  本发明涉及咪唑并[5,4-c]吡啶或吡咯并[3,2-c]吡啶化合物及其立体异构体形式、溶剂化合物、水合物和/或这些化合物的药学上可接受的盐，以及包含至少一种这些基于吡啶的双环化合物的药物组合物，与药学上可接受的载体、赋形剂和/或稀释剂一起。所述基于吡啶的双环化合物被假定为GRK5蛋白的调节剂，从而调节胰岛素的表达和/或释放，并可用于治疗或预防代谢性疾病，特别是用于糖尿病、肥胖和受损脂肪生成的治疗和预防。
• Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: From anti-pestivirus to anti-hepatitis C virus activity
  作者：Gerhard Puerstinger、Jan Paeshuyse、Erik De Clercq、Johan Neyts

  DOI：10.1016/j.bmcl.2006.10.039

  日期：2007.1

  A novel class of inhibitors of the hepatitis C virus [substituted 2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridines] is described. Introduction of a fluorine in position 2 of the 2-phenyl substituent of the lead anti-pestivirus compound 1 (5-[(4-bromophenyl)methyl]-2-phenyl-5H-imidazo[4,5-c]pyridine) resulted in an analogue with selective activity against HCV in the subgenomic replicon system.

  描述了新型的丙型肝炎病毒抑制剂[取代的2-（2-氟苯基）-5H-咪唑并[4,5-c]吡啶]。导致在抗瘟病毒的先导化合物1（5-[（4-溴苯基）甲基] -2-苯基-5H-咪唑并[4,5-c]吡啶）的2-苯基取代基的2位引入氟在亚基因组复制子系统中具有针对HCV的选择性活性的类似物。
• Metal-Mediated Inhibition of <i>Escherichia </i><i>c</i><i>oli</i> Methionine Aminopeptidase:  Structure−Activity Relationships and Development of a Novel Scoring Function for Metal−Ligand Interactions
  作者：Rolf Schiffmann、Alexander Neugebauer、Christian D. Klein

  DOI：10.1021/jm050476z

  日期：2006.1.1

  We report the discovery of thiabendazole as a potent inhibitor (K-i = 0.4 mu M) of Escherichia coli methionine aminopeptidase (ecMetAP) and the synthesis and pharmacological evaluation of thiabendazole congeners with activity in the upper nanomolar range. Elucidation of the X-ray structure of ecMetAP in complex with thiabendazole and an unrelated inhibitor that was independently described by another group showed that that both compounds bind to an additional Coll ion at the entrance of the active site. This unexpected finding explains the inactivity of the compounds under in vivo conditions. It also allows us to discuss the structure-activity relationships of this series of compounds in a meaningful way, based upon docking runs with an auxiliary metal ion. We describe a new scoring function for the evaluation of metal-mediated inhibitor binding that, unlike the previously used scoring function implemented in the docking program, allows us to distinguish between active and inactive compounds. Finally, conclusions for the structure-based design of in vivo-active inhibitors of ecMetAP are drawn.
• US4281005A
  申请人：——

  公开号：US4281005A

  公开（公告）日：1981-07-28
• Synthesis and PMR spectra of 2-hetaryl-substituted imidazo[4,5-b]-pyridines and imidazo[4,5-c]pyridines
  作者：Yu. M. Yutilov、L. I. Shcherbina、A. F. Efremenko

  DOI：10.1007/bf00472751

  日期：1989.7